1. Enhanced anti-angiogenic effects of bevacizumab in glioblastoma treatment upon intranasal administration in polymeric nanoparticles
   Flávia Sousa et al, 2019, Journal of Controlled Release CrossRef
2. Advances in Glioblastoma Therapy: An Update on Current Approaches
   Ramcharan Singh Angom et al, 2023, Brain Sciences CrossRef
3. Molecular and Cellular Complexity of Glioma. Focus on Tumour Microenvironment and the Use of Molecular and Imaging Biomarkers to Overcome Treatment Resistance
   Silvia Valtorta et al, 2020, International Journal of Molecular Sciences CrossRef
4. Anti-metastatic effect of 131I-labeled Buthus�martensii Karsch chlorotoxin in gliomas
   Shan Wu et al, 2018, International Journal of Molecular Medicine CrossRef
5. Some features controlling the blood D-dimer level after resection of malignant brain glioma
   I. D. Rozanov et al, 2017, Voprosy neirokhirurgii imeni N.N. Burdenko CrossRef
6. Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma
   N. García-Romero et al, 2020, BMC Medicine CrossRef
7. Therapy-induced shaping of the glioblastoma microenvironment: Macrophages at play
   Johanna Erbani et al, 2022, Seminars in Cancer Biology CrossRef
8. Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy
   Michele Patrizii et al, 2018, Frontiers in Oncology CrossRef
9. Chemotherapeutics and Their Efficacy
   H. Westley Phillips et al, 2016, Glioblastoma CrossRef
10. Passive Immunotherapies for Central Nervous System Disorders: Current Delivery Challenges and New Approaches
    Niyanta N. Kumar et al, 2018, Bioconjugate Chemistry CrossRef